Skin Cancers after Organ Transplantation

Abstract

ong-term survival after organ transplantation is increasing. As a result, many physicians may encounter patients who have long-term complications of transplantation. Adequate graft function requires lifelong immunosuppressive treatment, and the resultant modification of the immune system is associated with an increased risk of various cancers, particularly those involving viruses. Skin cancers are the most common malignant conditions in transplant recipients 1-4 (Table 1) and account for substantial morbidity and mortality in such patients. In this review, we discuss the most common forms of skin cancer in transplant recipients. Squamous-cell and basal-cell carcinomas account for more than 90 percent of all skin cancers in transplant recipients. 1,3,5,6 The incidence of these carcinomas increases with the duration of immunosuppressive therapy, ultimately affecting 50 percent or more of white transplant recipients. 1,5,7 For example, the cumulative incidence of skin cancer in transplant recipients in Queensland, Australia, increases from 7 percent after 1 year of immunosuppressive therapy 5 to 82 percent after 20 years. 8 Among Dutch transplant recipients, the incidence of skin cancer at one year is 0.2 percent and the long-term incidence is 41 percent. 5 Squamous-cell carcinoma is the most common skin cancer in transplant recipients, occurring 65 to 250 times as frequently as in the general population. 6,7,9 The incidence of basal-cell carcinomas is reportedly increased by a factor of 10 in transplant recipients. 7 The risk appears to increase linearly for basal-cell carcinomas and exponentially for squamous-cell carcinomas 1 ; thus, the ratio of squamous-cell to basal-cell carcinomas in patients without transplants (1:4) is reversed in transplant recipients. 1,5,10 The relative risk of squamous-cell carcinoma after transplantation is higher for men than for women, except for cancers of the lip. 9 Curiously, skin cancers appear to be extremely rare in Japanese patients with transplants. 11 The mean interval between transplantation and diagnosis of a tumor is eight years for patients who received transplants at approximately 40 years of age, 10 but is only about three years for those who received transplants after the age of 60. 1 The severity of these tumors is linked to their number. Approximately 30 to 50 percent of patients with squamous-cell carcinomas also have basal-cell carcinomas. 5,10 According to a Scandinavian study, 25 percent of patients with a first squamous-cell carcinoma will have a second lesion within 13 months, and 50 percent will have a second lesion within 3.5 years. 9 Liddington et al. reported a mean interval of 15 months between detection of the first and second cancers, and 11 months between the second and third. 12 Carcinomas are usually associated with multiple warts and premalignant keratoses, and are often associated with Bowen's disease (an intraepidermal carcinoma of the skin or mucous membranes that may progress to invasive carcinoma) and keratoacanthomas (Fig. 1A). The appearance ...

Improved detection reveals active β-papillomavirus infection in skin lesions from kidney transplant recipients

“…[5][6][7][8][9] Of the cancers presenting in organ transplant recipients that have no established infectious etiology, skin cancer is the most frequent form (95%), including squamous and basal cell carcinomas. [10][11][12][13] The incidence of skin cancer, the most common cancer in fair-skinned populations, is at least 50-fold higher in organ transplant recipients. [14][15][16] Large numbers of skin tumors (often more than 10) tend to develop over time in these at-risk subjects, thus presenting an enormous challenge for the patients and those responsible for their care.…”

Incidence of de novo cancer and lymphoproliferative disorders after liver transplantation in relation to age and duration of follow-up

“…29,30,[33][34][35] The incidence is extremely high in the Australian reports and is lowest in the Japanese studies. 34 The overall incidence reported from various studies ranges from 30% to 70% for all tumors after LTx. 24,38,39 Oropharyngeal and Lung Cancer…”

“…Nonmelanoma, non-Kaposi's skin cancers (squamous cell cancer and basal cell carcinoma) are the commonest types of de novo malignancies in the posttransplant population, with an up to 70 times higher incidence in comparison with nontransplant populations. 24,30,[33][34][35] One way to report this is to separate lymphoid lesions from nonlymphoid cancers and then separate the nonlymphoid cancers. Even after stratification of lymphoid and nonlymphoid cancers in this manner, there appears to be a wide variation in the different types of de novo cancers.…”

Human papillomavirus and posttransplantation cutaneous squamous cell carcinoma: A multicenter, prospective cohort study

“…The incidence of cSCC and BCC increases with duration of immunosuppressive therapy 1. Important risk factors are male sex, increasing age, fair skin type, sun exposure, and smoking 3.…”